Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (5)
Type
Type
Guidance (123)
NICE advice (19)
Quality standard (8)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (1)
Clinical guidelines (11)
Diagnostics guidance (4)
Health technology evaluations (2)
Highly specialised technologies guidance (5)
Interventional procedures guidance (22)
Medical technologies guidance (12)
NICE guidelines (18)
Public health guidelines (5)
Social care guidelines (3)
Technology appraisal guidance (60)
Advice programme
Advice programme
Evidence summaries (2)
Medtech innovation briefings (17)
Apply filters
Showing 101 to 125 of 150
Sort by
Date
Title
Apply sorting
Last updated date between 1/2/2022 and 31/8/2022
Remove Last updated date between 1/2/2022 and 31/8/2022 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Pralsetinib for treating RET fusion-positive advanced non-small-cell lung cancer
TA812
3 August 2022
3 August 2022
PredictSURE IBD and IBDX to guide treatment of Crohn's disease
DG45
23 February 2022
23 February 2022
Preterm labour and birth
NG25
20 November 2015
10 June 2022
ProciseDx point-of-care platform for inflammatory bowel disease
MIB302
12 July 2022
12 July 2022
Prontosan for treating acute and chronic wounds
MTG67
8 March 2022
8 March 2022
Reducing sexually transmitted infections
NG221
15 June 2022
15 June 2022
RespiraSense for continuously monitoring respiratory rate
MIB299
5 July 2022
5 July 2022
Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDs
TA803
13 July 2022
13 July 2022
Romosozumab for treating severe osteoporosis
TA791
25 May 2022
25 May 2022
Roxadustat for treating symptomatic anaemia in chronic kidney disease
TA807
13 July 2022
13 July 2022
Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapies
TA819
17 August 2022
17 August 2022
SecurAcath for securing percutaneous catheters
MTG34
5 June 2017
10 August 2022
SecurePort IV tissue adhesive for use with percutaneous catheters
MIB288
15 March 2022
15 March 2022
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over
HST20
5 May 2022
5 May 2022
Setmelanotide for treating obesity caused by LEPR or POMC deficiency
HST21
6 July 2022
6 July 2022
Sleepio to treat insomnia and insomnia symptoms
MTG70
20 May 2022
20 May 2022
Social work with adults experiencing complex needs
NG216
26 May 2022
26 May 2022
Social, emotional and mental wellbeing in primary and secondary education
NG223
6 July 2022
6 July 2022
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea
TA777
9 March 2022
9 March 2022
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer
TA781
30 March 2022
30 March 2022
Stereotactic radiosurgery for trigeminal neuralgia
IPG715
2 February 2022
2 February 2022
Stockholm3 for prostate cancer screening
MIB303
9 August 2022
9 August 2022
Stroke and transient ischaemic attack in over 16s: diagnosis and initial management
NG128
1 May 2019
13 April 2022
Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis
IPG726
25 May 2022
25 May 2022
Superficial venous arterialisation for chronic limb threatening ischaemia
IPG736
24 August 2022
24 August 2022
Previous page
1
3
4
Current page
5
6
Page
5
of
6
Next page
Results per page
10
25
50
All
Back to top